NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-767 Cr | ₹-128 Cr | ₹-205 Cr | ₹-186 Cr | ₹-119 Cr |
What is the latest Cash Flow from Financing Activities ratio of NECTAR LIFESCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-767 Cr |
| Mar2025 | ₹-128 Cr |
| Mar2024 | ₹-205 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹-119 Cr |
How is Cash Flow from Financing Activities of NECTAR LIFESCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-767 Cr | Negative | |
| Mar2025 | ₹-128 Cr | Negative | |
| Mar2024 | ₹-205 Cr | Negative | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹-119 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹201.3 Cr | -3.9% | -3.8% | -20.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -3.9% |
-3.8% |
-20.4% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses